The podcast of the American College of Clinical Pharmacy (ACCP). Offers interviews about a variety of clinical topics, interviews with influencers in clinical pharmacy, and overview of various research topics.
Esketamine nasal spray for treatment resistant depression - Ep 47
Dr. Autumn Walkerly provides an overview of Spravato (esketamine) nasal spray for treatment resistant depression.
Gaynes BN, Lux L, Gartlehner G, et al. Defining treatment-resistant depression. Depress Anxiety. 2020;37(2):134-45.
Irwin MN, VandenBerg A. Retracing our steps to understand ketamine in depression: A focused review of hypothesized mechanisms of action. Ment Health Clin. 2021;11(3):200-10.
Rush AJ, Trivedi MH, Wisniewski SR, et al. "Acute and longer-term outcomes in depressed outpatient requiring one or several treatment steps: A STAR*D report". Am J Psychiatry. 2006. 163(11):1905-17.
Daly EJ, Trivedi MH, Janik A, et al. Efficacy of esketamine nasal spray plus oral antidepressant treatment for relapse prevention in patients with treatment-resistant depression: a randomized clinical trial. JAMA Psychiatry. 2019;76(9):893-903.
Fu DJ, Ionescu DF, Li X, et al. Esketamine nasal spray for rapid reduction of major depressive disorder symptoms in patients who have active suicidal ideation with intent: double-blind, randomized study (ASPIRE I). J Clin Psychiatry. 2020;81(3):19m13191.
Popova V, Daly EJ, Trivedi M, et al. Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: a randomized double-blind active-controlled study. Am J Psychiatry. 2019;176(6):428-38.
Pharm.D. to Research Pathway: ACCP Podcast for Residents by Residents - Ep 46
Dr. Aaron Devanathan provides perspective on advancing your research career via the fellowship or Ph.D. route.
Bauman JL, Evans WE. Pharm.D.-only Investigators Are Critical to the Profession: Let’s Preserve the Fellowship as an Equally Important Way to Prepare Future Clinical Pharmaceutical Scientists: Or the Case Against the “All-Ph.D.” Pharmacotherapy. 2009 February;29(2):129–133. https://doi.org/10.1592/phco.29.2.129.
O’Donnell JM, Anand S, Brown SD, et al. Report of the 2018-2019 Research and Graduate Affairs Committee. Am J of Pharm Ed. 2019;83(10):Article 7595.
Assemi M, Suchanek Hudmon K, Sowinski KM, Corelli RL. Educational Background and Academic Rank of Faculty Members within US Schools of Pharmacy. Am J of Pharm Ed. 2016;80(4):Article 61.
Morbitzer KA, McLaughlin JE, Devanathan AS, et al. How-to guide for overcoming barriers of research and scholarship training in Pharm.D. and pharmacy residency programs. J Am Coll Clin Pharm. 2021;1-11. https://doi.org/10.1002/jac5.1426.
Pursuing a Career in Academia: ACCP Podcast for Residents by Residents - Ep 45
ACCP Podcast for Residents by Residents: Dr. Monica Xi discusses careers in academia for residency trained pharmacists with Dr. Jeremy Daniel, Pharm.D., BCPS, BCPP, associate professor at South Dakota State University College of Pharmacy and Allied Health Professions.
Young S, Vos SS, Cantrell M, Shaw R. Factors associated with students' perception of preceptor excellence. Am J Pharm Educ. 2014 Apr 17;78(3):53. doi: 10.5688/ajpe78353.
PAD; management of pain, agitation, and delirium in COVID-19 patients - ACCP Podcast for Residents by Residents: Ep 44
Episode 44: ACCP Podcast for Residents by Residents: PAD; management of pain, agitation, and delirium in COVID-19 patients
Adams CD, Altshuler J, Barlow BL, et al. Analgesia and Sedation Strategies in Mechanically Ventilated Adults with COVID-19. Pharmacotherapy 2020;40(12):1180–1191. doi: 10.1002/phar.2471.
Devlin JW, O’Neal Jr. HR, Thomas C, et al. Strategies to Optimize ICU Liberation (A to F) Bundle Performance in Critically Ill Adults With Coronavirus Disease 2019. Crit Care Expl 2020; 2:e0139. DOI: 10.1097/CCE.0000000000000139.
Devlin JW, Skrobik Y, Gelinas C, et al. Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU. Crit Care Med 2018;46(9):e825-73. DOI: 10.1097/CCM.0000000000003299.
Alhazzani W, Evans L, Alshami F, et al. Surviving Sepsis Campaign Guidelines on the Management of Adults with Coronavirus Disease 2019 (COVID-19) in the ICU. Crit Care Med 2021;49(3):e219-34.
National Heart, Lung, and Blood Institute PETAL Clinical Trials Network, Moss M, Huang DT, Brower RG, et al. "Early neuromuscular blockade in the acute respiratory distress syndrome". N Engl J Med. 2019. 380(21):1997-2008.
Papazian L, Forel J, Gacouin A, et al. "Neuromuscular blockers in early acute respiratory distress syndrome". N Engl J Med. 2010. 363(12):1107-1116.
Answers to so many questions about board certification, ACCP Podcast for Residents by Residents - Ep 43
Episode 43: ACCP Podcast for Residents by Residents: Answers to so many questions about board certification
Oral Antibiotic Agents for Gram Negative Bacteremias, ACCP Podcast for Residents by Residents - Ep 42
Episode 42: ACCP Podcast for Residents by Residents: Use of Oral Antibiotic Agents for Gram Negative Bacteremias